USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/7382
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAndronic, S.
dc.date.accessioned2020-02-06T12:59:23Z
dc.date.available2020-02-06T12:59:23Z
dc.date.issued2014-08
dc.identifier.citationANDRONIC, Serghei. Eficacitatea administrării parabulbare a bioreglatorului peptidic Retinalamin la pacienţii cu degenerescenţă maculară legată de vârstă. In: Curierul Medical. 2014, nr. 4(57), pp. 31-36. ISSN 1875-0666.en_US
dc.identifier.issn1875-0666
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/7382
dc.descriptionDepartment of Ophthalmology, Nicolae Testemitsanu State University of Medicine and Pharmacy Chisinau, the Republic of Moldovaen_US
dc.description.abstractBackground: One of the basic problems of contemporary medicine in the diagnosis and treatment remains the age-related macular degeneration (AMD). This is a pathology that affects the macular area of the retina, progresses and manifests itself by chronic degenerative processes of the retina. AMD is the leading cause of central vision loss linked to a sighth less than 0.05 – to the population over 65. Material and methods: The study includes 68 patients (136 eyes) with AMD in the period 2010-2013. The patients were devided into two lots: the basic group (38 patients, 76 eyes) that received parabulbar treatment with peptidic bioreglator Retinalamin and the control group (30 patients, 60 eyes) that followed traditional treatment with angioprotector preparations. Patients were subjected to AV, CVC and TCO examination before and after the treatment. Results: the visual functions improved to the basic group of patients beginning with the fifth day of treatment and continued to grow until the tenth day, maintaining constant for a month from the treatment too. Visual acuity increased in 97.22% cases and scotoma surface decreased by 50,9% in comparison with the control group. Conclusions: Retinalamin facilitates the restoration of retinal photosensitivity for the patients with AMD subjected to the treatment, exerting a specific stimulatory action on retinal photoreceptors, improves functional interactions between pigment epithelium and external segments of photoreceptors that leads to the increase in visual acuity and central scotoma decrease.en_US
dc.language.isoroen_US
dc.publisherCurierul medicalen_US
dc.subjectage-related macular degenerationen_US
dc.subjectoptical coherence tomographyen_US
dc.subjectretinalaminen_US
dc.titleThe efficacy of parabulbar administration of the Retinalamin peptide bioregulator in the patients with age-related macular degenerationen_US
dc.title.alternativeEficacitatea administrării parabulbare a bioreglatorului peptidic Retinalamin la pacienţii cu degenerescenţă maculară legată de vârstăen_US
dc.typeArticleen_US
Appears in Collections:Curierul Medical, 2014, Vol. 57, Nr. 4

Files in This Item:
File Description SizeFormat 
Eficacitatea_administrarii_parabulbare_a_bioreglatorului_peptidic_Retinalamin.pdf1.9 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback